tiprankstipranks
Trending News
More News >
Mirion Technologies, Inc. (MIR)
:MIR
Advertisement

Mirion Technologies (MIR) AI Stock Analysis

Compare
433 Followers

Top Page

MIR

Mirion Technologies

(NYSE:MIR)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 4o)
Rating:68Neutral
Price Target:
$27.00
▼(-9.24% Downside)
Mirion Technologies' overall score is driven by strong financial performance and positive technical indicators. The earnings call provided a positive outlook, particularly in the nuclear power sector. However, the high P/E ratio suggests overvaluation, which weighs down the overall score.
Positive Factors
Revenue Growth
The consistent revenue growth indicates strong demand for Mirion's products, particularly in the nuclear power sector, supporting long-term business expansion.
Cash Flow Management
Strong cash flow management enhances financial flexibility, allowing Mirion to invest in growth opportunities and manage debt efficiently.
Nuclear Power Market Position
Mirion's growth in the nuclear power sector underscores its competitive position and potential for continued success in a critical industry.
Negative Factors
U.S. Medical Segment Challenges
Ongoing challenges in the U.S. medical segment could hinder revenue growth and profitability, impacting Mirion's overall performance.
Low Return on Equity
Low return on equity suggests inefficiencies in using shareholder capital, which could affect investor confidence and long-term growth.
Challenges in Labs and Research End Market
Reduced demand in the labs and research market may limit growth opportunities and revenue diversification for Mirion.

Mirion Technologies (MIR) vs. SPDR S&P 500 ETF (SPY)

Mirion Technologies Business Overview & Revenue Model

Company DescriptionMirion Technologies (MIR) is a leading provider of radiation detection and measurement solutions, serving a diverse range of sectors including nuclear power, medical, military, and research. The company specializes in advanced technologies for radiation safety, offering a comprehensive portfolio of products such as personal dosimeters, radiation monitoring systems, and imaging solutions. Mirion is committed to delivering innovative solutions that ensure safety and compliance in environments where radiation exposure is a concern.
How the Company Makes MoneyMirion Technologies generates revenue through multiple key streams, primarily from the sale of its radiation detection and measurement equipment, including dosimeters and monitoring systems. The company also earns income through maintenance and service contracts, providing ongoing support and calibration for its products. Additionally, Mirion benefits from strategic partnerships with key players in the nuclear and healthcare industries, allowing it to expand its market reach and enhance its product offerings. Government contracts and regulatory compliance services further contribute to its revenue, as organizations increasingly prioritize safety in radiation exposure management.

Mirion Technologies Earnings Call Summary

Earnings Call Date:Oct 28, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 17, 2026
Earnings Call Sentiment Positive
The earnings call highlights strong financial performance and growth in the nuclear power end market, alongside improvements in cost of debt and free cash flow. However, challenges in the U.S. medical segment and labs and research end market present some concerns. Overall, the positive developments in nuclear power and financial metrics outweigh the challenges faced.
Q3-2025 Updates
Positive Updates
Strong Third Quarter Results
Third quarter revenue totaled $223 million, a nearly 8% increase from last year's third quarter. Adjusted EBITDA was $52.4 million, up 14.7% versus third quarter last year.
Nuclear Power End Market Growth
Nuclear power end market organic revenue grew 9% in the quarter and 11% year-to-date. Adjusted orders increased 21% in the quarter.
Cost of Debt Improvement
Year-end 2025 expected blended cost of debt of 2.8%, reflecting a 460 basis point improvement over the past year.
Positive Free Cash Flow
Third quarter adjusted free cash flow was $18 million, contributing to $53 million of year-to-date adjusted free cash flow. Adjusted free cash flow guidance increased to between $100 million and $115 million.
Medical Segment Progress
Third quarter organic revenue from dosimetry services grew 7% with digital offerings leading. Medical segment margins expanded 120 basis points to 35.9%.
Negative Updates
Pressure in U.S. Medical Segment
Current U.S. health care environment is pressuring the U.S. RTQA business, with timing and magnitude of a rebound remaining clouded due to government shutdown headwinds.
Challenges in Labs and Research End Market
Demand from the U.S. Department of Energy has been muted since the launch of DOGE and the government shutdown. Order flow from China for laboratory instruments has slowed.
Order Decline in Medical Segment
Adjusted orders in the Medical segment declined $4.7 million, primarily due to RTQA end markets' performance.
Company Guidance
In the Mirion Technologies Third Quarter 2025 Earnings Conference Call, the company provided robust guidance, emphasizing their strong performance and optimistic outlook for the nuclear power end market. Mirion reported a third-quarter revenue of $223 million, marking an 8% increase from the previous year, with organic revenue growth at 4.7%. Adjusted EBITDA rose by 14.7% to $52.4 million, driven by both the Nuclear and Safety and Medical segments, contributing to a 140 basis point margin expansion. The company highlighted the nuclear power end market, with organic revenue growth of 9% for the quarter and 11% year-to-date. Notably, Mirion raised the low end of their adjusted free cash flow guidance for 2025 to between $100 million and $115 million, driven by strong performance, and expects a conversion of 45% to 49% of adjusted EBITDA. Moreover, they reported third-quarter adjusted orders growth of 2.4%, particularly in the nuclear power sector, with significant SMR orders and newbuild projects under the EDF strategic agreement. The company reiterated its strategic acquisitions, such as Paragon Energy Solutions and Certrec, as pivotal to enhancing its portfolio and expanding its presence in the nuclear industry.

Mirion Technologies Financial Statement Overview

Summary
Mirion Technologies shows strong revenue growth and improved profitability with a positive net profit margin. The balance sheet is stable with a solid equity base, though leverage should be monitored. Cash flow management is robust, with significant free cash flow generation.
Income Statement
75
Positive
Mirion Technologies has shown a strong improvement in revenue, with a notable revenue growth rate from 2024 to TTM (Trailing-Twelve-Months). The gross profit margin is healthy at 51.7% for TTM. Despite past losses, the net profit margin has turned positive at 1.7% in TTM, indicating improved profitability. The EBIT and EBITDA margins are relatively low, with an EBIT margin of 5.6% and EBITDA margin of 3.8%, indicating room for improvement in operational efficiency.
Balance Sheet
65
Positive
The company has a solid equity base with a high equity ratio of 55.3% in TTM, reflecting financial stability. However, the debt-to-equity ratio remains moderate at 0.28, which suggests a balanced approach to leverage but still poses a potential risk if not managed carefully. The return on equity is relatively low at 1.3%, indicating limited returns on shareholders' equity.
Cash Flow
80
Positive
Free cash flow has shown significant growth, with a substantial increase from the previous year, highlighting strong cash generation capabilities. The operating cash flow to net income ratio is robust at 8.64, indicating efficient cash utilization. The free cash flow to net income ratio is also strong at 5.97, underscoring effective cash flow management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue902.30M860.80M800.90M717.80M322.10M478.20M
Gross Profit425.40M399.70M356.40M317.20M81.10M197.00M
EBITDA208.60M174.40M149.00M-90.80M-19.20M22.88M
Net Income26.50M-36.10M-96.90M-276.90M-127.90M-1.04M
Balance Sheet
Total Assets3.50B2.64B2.72B2.74B3.12B751.32M
Cash, Cash Equivalents and Short-Term Investments933.20M181.10M134.10M77.80M88.90M383.25K
Total Debt1.23B719.90M721.00M849.60M860.60M1.70B
Total Liabilities1.60B1.08B1.17B1.27B1.33B27.59M
Stockholders Equity1.84B1.51B1.48B1.40B1.69B652.05M
Cash Flow
Free Cash Flow122.25M50.30M58.10M5.20M-16.70M-20.85M
Operating Cash Flow132.40M99.10M95.20M39.40M900.00K-945.35K
Investing Cash Flow-113.40M-43.70M-64.70M-39.50M-2.20B-75.60M
Financing Cash Flow776.10M-3.30M22.60M-7.00M1.54B751.39M

Mirion Technologies Technical Analysis

Technical Analysis Sentiment
Positive
Last Price29.75
Price Trends
50DMA
23.02
Positive
100DMA
22.00
Positive
200DMA
18.94
Positive
Market Momentum
MACD
0.89
Negative
RSI
74.03
Negative
STOCH
76.43
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MIR, the sentiment is Positive. The current price of 29.75 is above the 20-day moving average (MA) of 24.30, above the 50-day MA of 23.02, and above the 200-day MA of 18.94, indicating a bullish trend. The MACD of 0.89 indicates Negative momentum. The RSI at 74.03 is Negative, neither overbought nor oversold. The STOCH value of 76.43 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MIR.

Mirion Technologies Risk Analysis

Mirion Technologies disclosed 46 risk factors in its most recent earnings report. Mirion Technologies reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Mirion Technologies Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
$8.76B15.3220.97%1.22%3.19%69.89%
$4.02B27.3217.33%1.03%10.19%20.71%
$3.54B34.5211.25%0.45%-0.96%-11.55%
$6.40B618.921.58%7.81%
$4.10B28.9315.79%0.22%12.27%19.05%
$10.79B15.437.44%2.01%2.89%-14.66%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MIR
Mirion Technologies
29.75
15.00
101.69%
FLS
Flowserve
68.95
16.03
30.29%
KAI
Kadant
300.88
-33.40
-9.99%
MWA
Mueller Water Products
25.69
3.79
17.31%
CSW
CSW Industrials
244.08
-115.09
-32.04%

Mirion Technologies Corporate Events

Mirion Technologies Reports Strong Q3 2025 Results
Oct 30, 2025

Mirion Technologies, Inc. is a global leader in radiation detection and monitoring solutions, serving the nuclear, medical, defense, and research industries with innovative safety technologies. In its latest earnings report, Mirion announced a 7.9% increase in third-quarter revenue, reaching $223.1 million, alongside a significant turnaround to a GAAP net income of $3.1 million from a net loss in the previous year. The company also reported a 14.7% rise in adjusted EBITDA to $52.4 million, and adjusted earnings per share increased to $0.12 from $0.08. Mirion’s strategic initiatives include the acquisition of Paragon Energy Solutions to enhance its U.S. nuclear power market presence, complementing the earlier acquisition of Certrec. These moves are expected to increase the company’s nuclear power-based revenue to approximately 45% of total revenue. Looking ahead, Mirion remains optimistic, reaffirming its 2025 guidance for revenue growth and adjusted financial metrics, while raising the lower end of its adjusted free cash flow guidance, signaling confidence in achieving its full-year targets.

M&A TransactionsPrivate Placements and Financing
Mirion Technologies Completes Convertible Notes Offering
Neutral
Sep 30, 2025

On September 25, 2025, Mirion Technologies announced an underwriting agreement with Goldman Sachs and Evercore for a public offering of 19,906,322 shares of Class A common stock, raising approximately $409.7 million. The proceeds, along with funds from a concurrent $375 million Convertible Notes Offering, are intended to finance capped call transactions and the acquisition of WCI-Gigawatt Intermediate Holdco, LLC, with any remaining funds used for general corporate purposes. The Convertible Notes Offering, completed on September 30, 2025, includes provisions for conversion and redemption, with a maturity date set for October 1, 2031.

The most recent analyst rating on (MIR) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on Mirion Technologies stock, see the MIR Stock Forecast page.

Business Operations and StrategyM&A Transactions
Mirion Technologies Acquires Paragon Energy for $585 Million
Positive
Sep 25, 2025

On September 24, 2025, Mirion Technologies announced its acquisition of Paragon Energy Solutions for $585 million in an all-cash transaction. This strategic move is expected to enhance Mirion’s market position by integrating Paragon’s operations, potentially generating commercial and cost synergies, although the deal is subject to regulatory approvals and customary closing conditions.

The most recent analyst rating on (MIR) stock is a Hold with a $27.00 price target. To see the full list of analyst forecasts on Mirion Technologies stock, see the MIR Stock Forecast page.

Mirion Technologies Confronts Global Economic and Geopolitical Challenges
Aug 3, 2025

Mirion Technologies, Inc. faces significant risks from global economic conditions and geopolitical tensions, which could adversely affect its operations and financial performance. The uncertainty surrounding international trade relationships, particularly between the U.S. and countries like China, Canada, and the EU, poses a threat to the company’s revenue and profitability. Tariffs, export controls, and trade barriers could increase costs and disrupt supply chains, while geopolitical tensions might lead to cyberattacks and fluctuating commodity prices. With 37% of its revenue generated outside North America, Mirion Technologies must navigate these challenges to maintain its competitive edge and financial stability.

Mirion Technologies Reports Strong Q2 2025 Results
Aug 2, 2025

Mirion Technologies, Inc. is a global leader in radiation safety, science, and medicine, providing solutions across nuclear, medical, defense, and research sectors. The company has announced its second quarter 2025 financial results, showcasing a significant improvement in its financial performance compared to the same period last year. Mirion reported a 7.6% increase in revenue, reaching $222.9 million, and a GAAP net income of $8.5 million, a notable turnaround from the previous year’s loss.

Mirion Technologies’ Earnings Call Highlights Growth and Strategic Moves
Aug 2, 2025

Mirion Technologies Reports Positive Earnings Call with Promising Growth Prospects

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 30, 2025